Suppr超能文献

[关于中西医结合治疗新型冠状病毒肺炎的循证指南的建议]

[Proposal of Living Evidence-based Guideline for Combination of Traditional Chinese and Western Medicine for Treatment of COVID-19].

作者信息

Wang Qi, Hou Liang-Ying, Zhu Hong-Fei, Li Meng-Ting, Zhang Qian, Zhou Qi, Chen Yao-Long, Yang Ke-Hu, Shang Hong-Cai, Guo Xin-Feng, Wu Da-Rong, Ge Long

机构信息

Evidence-based Social Science Research Center, School of Public Health, Lanzhou University Lanzhou 730000, China Department of Social Science and Health Management, School of Public Health, Lanzhou University Lanzhou 730000, China.

School of Nursing, Lanzhou University Lanzhou 730000, China.

出版信息

Zhongguo Zhong Yao Za Zhi. 2021 Oct;46(19):5117-5122. doi: 10.19540/j.cnki.cjcmm.20210224.501.

Abstract

In order to standardize the clinical diagnosis and treatment decision-making with traditional Chinese medicine for pa-tients of coronavirus disease 2019(COVID-19) and put the latest clinical study evidence into clinical practice, the international trust-worthy traditional Chinese medicine recommendations( TCM Recs) working group started the compilation of Living Evidence-based Guideline for Combination of Traditional Chinese and Western Medicine for Treatment of COVID-19 on the basis of the standards and re-quirements of WHO handbook, GRADE and RIGHT. This proposal mainly introduces the formulation methods and processes of the living guidelines in details, such as the composition of the working group, the collection and identification of clinical issues and out-comes, the production of the living systematic review and the consensus of recommendations. The guidelines will continue to monitor the clinical study evidences of TCM in the prevention and treatment of COVID-19, and conduct regular evidence updating, retrieval and screening. When there is new study evidence, the steering committee will evaluate the possibility of the evidence to change clinical practice or previous recommendations, so as to decide whether the recommendations for the guidelines shall be implemented or upda-ted. The main criteria considered in the guideline updating are as follows:(1) There are new high-quality randomized controlled trial(RCT) evidences for TCM uninvolved in the previous edition of the guidelines;(2) as for the TCM involved in the guidelines, living sys-tematic review shows that new evidence may change the direction or strength of the existing recommendations. The specific implementation of the living evidence-based guidelines will take this proposal as the study basis and framework, in order to ensure the standardization of the formulation process and methods. This will be the first exploration of the methodology for living guidelines in the field of TCM.

摘要

为规范2019冠状病毒病(COVID-19)患者的中医临床诊断和治疗决策,并将最新的临床研究证据应用于临床实践,国际可信中医推荐(TCM Recs)工作组依据世界卫生组织手册、GRADE和RIGHT的标准及要求,启动了《中西医结合治疗COVID-19的循证动态指南》的编撰工作。本提案主要详细介绍了动态指南的制定方法和流程,如工作组的组成、临床问题和结局的收集与识别、动态系统评价的制作以及推荐意见的共识形成。该指南将持续监测中医防治COVID-19的临床研究证据,并定期进行证据更新、检索和筛选。当有新的研究证据时,指导委员会将评估该证据改变临床实践或既往推荐意见的可能性,以决定是否对指南的推荐意见进行实施或更新。指南更新时主要考虑的标准如下:(1)有关于中医的新的高质量随机对照试验(RCT)证据,且该证据未被纳入上一版指南;(2)对于指南中涉及的中医内容,动态系统评价显示新证据可能改变现有推荐意见的方向或强度。循证动态指南的具体实施将以本提案作为研究基础和框架,以确保制定过程和方法的规范化。这将是中医领域对动态指南方法学的首次探索。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验